TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34229862

Group type: COMPARATOR
Intervention: Levobupivacaine 0.25% plus normal saline
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25% plus dexmedetomidine 1 μg.kg‐1
Number of subjects: 70
Study: 32998517

Group type: EXPERIMENTAL
Intervention: U-13C18:0 (stearate)
Number of subjects: 6

Group type: COMPARATOR
Intervention: U-13C18:1 (oleate)
Number of subjects: 6
Study: 33578236

Group type: EXPERIMENTAL
Intervention: Cefprozil combined with Tanshinone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Tanshinone I
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Tanshinone IIA/B
Number of subjects: 58
Study: 33506278

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clinical model
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 90
Study: 32393349

Group type: EXPERIMENTAL
Intervention: Auxiliary nurse midwives conducting periodontal examinations
Number of subjects: 21
Study: 34913825

Group type: EXPERIMENTAL
Intervention: Econazole 250 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Econazole 500 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Econazole 1000 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 32456170

Group type: EXPERIMENTAL
Intervention: Physical activity group (running for ten minutes)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 51
Study: 35948889

Group type: EXPERIMENTAL
Intervention: SCT intervention (N=85)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual care (N=83)
Number of subjects: 168
Study: 33644986

Group type: EXPERIMENTAL
Intervention: Soft-tissue mobilization therapy and 20 spinal mobility exercises
Number of subjects: 21

Group type: COMPARATOR
Intervention: 20 spinal mobility exercises
Number of subjects: 21
Study: 36250322

Group type: EXPERIMENTAL
Intervention: iAE group (ClassIntra grade)
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: ClassIntra grade ≥II
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Higher ClassIntra grade, lower OSATS score, total gastrectomy
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 528
Study: 32338931

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive therapy (EBCT)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Both EBCT and CBT
Number of subjects: 149
Study: 36367856

Group type: EXPERIMENTAL
Intervention: Scenario-based virtual laboratory simulation (SB-VLS) on molecular cloning
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional lecture and video lab demonstration (VLD)
Number of subjects: 35
Study: 34491219

Group type: EXPERIMENTAL
Intervention: Children teaching parents using a booklet
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Children teaching parents without a booklet
Number of subjects: 142

Group type: COMPARATOR
Intervention: Children listening to an unrelated topic
Number of subjects: 142

Group type: COMPARATOR
Intervention: Parents learning from an expert
Number of subjects: 142

Group type: COMPARATOR
Intervention: Parents learning about an unrelated topic
Number of subjects: 142
Study: 32811734

Group type: EXPERIMENTAL
Intervention: Trimodal therapy consisting of 2% Nitroglycerine (NTG), Hyperbaric Oxygen Therapy (HBOT), and local steroids
Number of subjects: 82

Group type: COMPARATOR
Intervention: Nitroglycerine (NTG) and local steroids (without HBOT)
Number of subjects: 82
Study: 36454883

Group type: EXPERIMENTAL
Intervention: Non-face-to-face (NFF) CPR training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Face-to-face (FF) CPR training
Number of subjects: 70
Study: 34794222

Group type: EXPERIMENTAL
Intervention: MALDI‐TOF MS combined with magnetic bead technology
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Recombinant serglycin (SRGN) and fibrinogen alpha chain (FGA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 54
Study: 36309759

Group type: EXPERIMENTAL
Intervention: 125 mg oral bosentan, twice a day for 8 weeks
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 33627329

Group type: EXPERIMENTAL
Intervention: Dopamine infusion (standard management)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (5% dextrose) infusion (restrictive management)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Standard management
Number of subjects: 58

Group type: COMPARATOR
Intervention: Restrictive management
Number of subjects: 58
Study: 35648267

Group type: EXPERIMENTAL
Intervention: Slow withdrawal (160 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Rapid withdrawal (60 days)
Number of subjects: 48
Study: 34044534

Group type: EXPERIMENTAL
Intervention: Cyclic peptide inhibitors of FXIIa
Number of subjects: 0
Study: 32199006

Group type: EXPERIMENTAL
Intervention: Automatic proportional minute ventilation (APMV)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV‐p) or pressure control modes (PCV) without APMV
Number of subjects: 80
Study: 33287553

Group type: EXPERIMENTAL
Intervention: Singapore Physical Activity and Nutrition Study (SPANS) intervention group
Number of subjects: 580
Study: 34919634

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33124895

Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Levilactobacillus brevis CECT7480 and Lactoplantibacillus plantarum CECT7481), 2 tablets per day for 1 week
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 34639746

Group type: EXPERIMENTAL
Intervention: CPSCoD training (twice weekly for 8 weeks)
Number of subjects: 17
Study: 32417773

Group type: EXPERIMENTAL
Intervention: Hypertension (SBP≥140 mmHg) in age group 60-69
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Hypertension (SBP≥140 mmHg) and WMH in age group 50-59
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: WMH in age group ≥70
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Hypertension and WMH across age bands
Number of subjects: 488
Study: 36045965

Group type: EXPERIMENTAL
Intervention: Budesonide combined with loratadine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Mometasone furoate nasal spray combined with loratadine
Number of subjects: 120
Study: 32885676

Group type: EXPERIMENTAL
Intervention: High threat message with seeking cue
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: High threat message without seeking cue
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Low threat message with seeking cue
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Low threat message without seeking cue
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: No message with seeking cue
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: No message without seeking cue
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 1823
Study: 35584341

Group type: EXPERIMENTAL
Intervention: Endobronchial valves (BLVR)
Number of subjects: 24
Study: 33259771

Group type: EXPERIMENTAL
Intervention: Biologic mesh
Number of subjects: 87

Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 87
Study: 34417367

Group type: EXPERIMENTAL
Intervention: e‐CME
Number of subjects: 93

Group type: COMPARATOR
Intervention: s‐CME
Number of subjects: 93
Study: 33474945

Group type: EXPERIMENTAL
Intervention: Randomized response technique (RRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation sampling tests
Number of subjects: 0
Study: 32842953

Group type: EXPERIMENTAL
Intervention: Thrombectomy in acute stroke
Number of subjects: 0
Study: 36096534

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg) every 4 weeks until worsening or unacceptable toxicity
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg)
Number of subjects: 19
Study: 34160450

Group type: EXPERIMENTAL
Intervention: Dyslexic children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-dyslexic children
Number of subjects: 0
Study: 32094127

Group type: EXPERIMENTAL
Intervention: IMI-REL
Number of subjects: 72

Group type: COMPARATOR
Intervention: Colistin plus IMI
Number of subjects: 72
Study: 36183101

Group type: COMPARATOR
Intervention: Aqueous crystalline penicillin G (ACPG)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 290
Study: 36220337

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) treatment
Number of subjects: 318
Study: 33862593

Group type: EXPERIMENTAL
Intervention: Decompression plus fusion
Number of subjects: 608

Group type: COMPARATOR
Intervention: Decompression alone
Number of subjects: 608
Study: 35320174

Group type: EXPERIMENTAL
Intervention: Laparoscopic primary repair of defect with non-absorbable suture prior to mesh placement (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic repair without primary closure of the defect (Group B)
Number of subjects: 100
Study: 32610481

Group type: COMPARATOR
Intervention: e+ shot
Number of subjects: 30

Group type: COMPARATOR
Intervention: caffeine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: placebo
Number of subjects: 30
Study: 35304117

Group type: EXPERIMENTAL
Intervention: AI first colonoscopy
Number of subjects: 230

Group type: COMPARATOR
Intervention: Standard colonoscopy first
Number of subjects: 230
Study: 32341103

Group type: EXPERIMENTAL
Intervention: RAAS inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RAAS modulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed interventions for SARS-CoV-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modulation of downstream pathophysiologic effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RAAS-based interventions
Number of subjects: 0
Study: 35550621

Group type: EXPERIMENTAL
Intervention: CRP-based TB screening using a point-of-care (POC) assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Symptom-based TB screening (current practice)
Number of subjects: 0
Study: 34726874

Group type: EXPERIMENTAL
Intervention: Endoscopic stapedotomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Microscopic stapedotomy
Number of subjects: 22
Study: 32130328

Group type: EXPERIMENTAL
Intervention: OM‐85 BV
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 34890961

Group type: EXPERIMENTAL
Intervention: Compassionate Mind Training (CMT) program for caregivers of RYC
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study: 34632114

Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 50

Group type: COMPARATOR
Intervention: Denosumab
Number of subjects: 50
Study: 32955554

Group type: EXPERIMENTAL
Intervention: iCanQuit (ACT-based application)
Number of subjects: 2415

Group type: COMPARATOR
Intervention: QuitGuide (USCPG-based application)
Number of subjects: 2415
Study: 35550709

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 733
Study: 32974974

Group type: EXPERIMENTAL
Intervention: Occlusive PDT with 5-aminolevulinic acid (BF-200 ALA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Non-occlusive PDT with 5-aminolevulinic acid (BF-200 ALA)
Number of subjects: 45
Study: 34563559

Group type: EXPERIMENTAL
Intervention: Plasma-Lyte.½
Number of subjects: 104

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 104
Study: 32861372

Group type: EXPERIMENTAL
Intervention: Scapular Stabilization (SSG) exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Periscapular Strengthening (PSG) exercises
Number of subjects: 60
Study: 35441378

Group type: EXPERIMENTAL
Intervention: Intervention (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random intercept mixed effects linear regression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal allocation of units under a fixed cost
Number of subjects: 0
Study: 33471144

Group type: EXPERIMENTAL
Intervention: Restorelle® Y mesh
Number of subjects: 62

Group type: COMPARATOR
Intervention: Dual flat mesh
Number of subjects: 62
Study: 35914894

Group type: EXPERIMENTAL
Intervention: Driving pressure-guided ventilation (DP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Protective ventilation (PV)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups (DP and PV)
Number of subjects: 78
Study: 34253718

Group type: EXPERIMENTAL
Intervention: High SES households
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low SES households
Number of subjects: 0
Study: 33655814

Group type: EXPERIMENTAL
Intervention: Maximal fat oxidation (MFO) during a graded exercise test
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Intensity of exercise that elicits MFO (Fatmax) during a graded exercise test
Number of subjects: 119
Study: 34105321

Group type: EXPERIMENTAL
Intervention: Water-based rhythmic exercise training (12 weeks, 60 min, 3 times a week)
Number of subjects: 31
Study: 32415610

Group type: EXPERIMENTAL
Intervention: dd-cfDNA testing
Number of subjects: 175

Group type: COMPARATOR
Intervention: No dd-cfDNA testing (Control)
Number of subjects: 175
Study: 36070877

Group type: EXPERIMENTAL
Intervention: Health coaching (5 coaching sessions biweekly, 30-45 minutes each)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Health coaching
Number of subjects: 94
Study: 33721689

Group type: EXPERIMENTAL
Intervention: Treatment A (active)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Treatment B (passive)
Number of subjects: 38
Study: 33028707

Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation combining sound and tongue stimulation
Number of subjects: 326
Study: 33663733

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1498

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1498
Study: 33543227

Group type: EXPERIMENTAL
Intervention: Diode laser-assisted method (808 nm, 1.5 W laser with fiber diameter of 320 μm for hemorrhage control and 1W laser for decontamination)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 100
Study: 33349933

Group type: EXPERIMENTAL
Intervention: Early childhood PAE group
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Adolescent PAE group
Number of subjects: 83

Group type: COMPARATOR
Intervention: Adolescent control group
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Early childhood PAE group at 4-year follow-up
Number of subjects: 83
Study: 32517492

Group type: EXPERIMENTAL
Intervention: 3D fluoroscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2D fluoroscopy
Number of subjects: 100
Study: 36172728

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy (HFNO)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nasal oxygen breath (NOB)
Number of subjects: 180
Study: 34381706

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 853

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 853
Study: 32366450

Group type: EXPERIMENTAL
Intervention: High tie of the inferior mesenteric artery (IMA)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low tie of the inferior mesenteric artery (IMA)
Number of subjects: 56
Study: 36082663

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan 200 mg twice daily
Number of subjects: 544

Group type: COMPARATOR
Intervention: Ramipril 5 mg twice daily
Number of subjects: 544
Study: 32331024

Group type: EXPERIMENTAL
Intervention: AMPH ER TAB 20 mg swallowed (fasted)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AMPH ER TAB 20 mg chewed (fed/fasted)
Number of subjects: 32

Group type: COMPARATOR
Intervention: AMPH EROS 20 mg fasted
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AMPH ER TAB chewed (fasted) vs. fed
Number of subjects: 32
Study: 35559521

Group type: EXPERIMENTAL
Intervention: Creatine Nitrate (CN: 5 g/day + 0.675 g/day of maltodextrin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF: 400 mg/day + 5 g/day of maltodextrin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Creatine Nitrate + Caffeine (CN+CAF: 5 g/day of creatine nitrate + 400 mg/day of caffeine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PL: 5.4 g/day of maltodextrin)
Number of subjects: 12
Study: 32024498

Group type: EXPERIMENTAL
Intervention: Ozonized water (group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Double distilled water (group 2)
Number of subjects: 20
Study: 33927343

Group type: EXPERIMENTAL
Intervention: Selective progesterone receptor modulator (SPRM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35162512

Group type: EXPERIMENTAL
Intervention: Social Skills Group Training (SSGT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Active social control activities
Number of subjects: 20
Study: 33235172

Group type: EXPERIMENTAL
Intervention: Contact aspiration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Stent retriever
Number of subjects: 20
Study: 35346329

Group type: EXPERIMENTAL
Intervention: 8-session group advocacy training intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 0
Study: 33561756

Group type: EXPERIMENTAL
Intervention: Education plus navigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Education
Number of subjects: 0
Study: 32307878

Group type: EXPERIMENTAL
Intervention: 250 mg Sustanon® (testosterone ester injections)
Number of subjects: 19
Study: 34291892

Group type: EXPERIMENTAL
Intervention: Standard care plus the m‐Health intervention (Rheumatism Center app)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 33091917

Group type: EXPERIMENTAL
Intervention: Bandage Contact Lens (BCL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Eye Patching
Number of subjects: 40
Study: 32653333

Group type: EXPERIMENTAL
Intervention: Intravenous cetirizine 10 mg
Number of subjects: 262

Group type: COMPARATOR
Intervention: Intravenous diphenhydramine 50 mg
Number of subjects: 262
Study: 35482774

Group type: EXPERIMENTAL
Intervention: Adherence to aerobic exercise prescription (at least two-thirds of the prescribed exercise)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adherence during week 1 of aerobic exercise
Number of subjects: 0
Study: 34582445

Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 4138

Group type: EXPERIMENTAL
Intervention: Adolescent pregnancy
Number of subjects: 4138

Group type: EXPERIMENTAL
Intervention: HSV-2 infection
Number of subjects: 4138

Group type: EXPERIMENTAL
Intervention: Reported sexual activity
Number of subjects: 4138
Study: 34360490

Group type: EXPERIMENTAL
Intervention: Robot-assisted cognitive training (RACT)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Traditional cognitive training (TCT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: No intervention (NI)
Number of subjects: 135
Study: 36367979

Group type: EXPERIMENTAL
Intervention: Lithotomy position surgical warmer
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with heated environment, fluid, and upper abdomen
Number of subjects: 100
Study: 33666264

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (PC) in addition to traditional care
Number of subjects: 206

Group type: COMPARATOR
Intervention: Traditional care (Control Arm)
Number of subjects: 206
Study: 32590979

Group type: EXPERIMENTAL
Intervention: LDHF/m-mentoring
Number of subjects: 299

Group type: COMPARATOR
Intervention: TRAD
Number of subjects: 299
Study: 35044972

Group type: EXPERIMENTAL
Intervention: Topical natamycin 5% plus CXL
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Topical amphotericin B 0.15% plus CXL
Number of subjects: 111

Group type: COMPARATOR
Intervention: Topical natamycin 5% alone
Number of subjects: 111

Group type: COMPARATOR
Intervention: Topical amphotericin B 0.15% alone
Number of subjects: 111
Study: 34818273

Group type: EXPERIMENTAL
Intervention: Botulinum toxin Type A (BTX) intradermal injections to the treated side of the inframammary incision
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 27
Study: 35017306

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for acute ischemic stroke (AIS) in patients with active cancer
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for acute ischemic stroke (AIS) in patients with active cancer in a palliative treatment setting
Number of subjects: 124

Group type: COMPARATOR
Intervention: Endovascular treatment (EVT) for acute ischemic stroke (AIS) in patients without active cancer
Number of subjects: 124
Study: 32310691

Group type: EXPERIMENTAL
Intervention: Momiai (500 mg capsules)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (500 mg capsules)
Number of subjects: 160
Study: 35727801

Group type: EXPERIMENTAL
Intervention: Human coaching
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AI chatbot coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study: 32492040

Group type: EXPERIMENTAL
Intervention: Traumatic hemorrhage patients
Number of subjects: 20207

Group type: EXPERIMENTAL
Intervention: Postpartum hemorrhage patients
Number of subjects: 20207
Study: 35184324

Group type: EXPERIMENTAL
Intervention: Medication consultation (additional consultation with a physician)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Medication consultation
Number of subjects: 408

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 408
Study: 34795574

Group type: EXPERIMENTAL
Intervention: Virtual reality-based therapy combined with conventional functional training (1 hour of functional training + 1 hour of virtual reality therapy using Armeo Spring equipment)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional functional training (2 hours of conventional functional training)
Number of subjects: 40
Study: 32682408

Group type: EXPERIMENTAL
Intervention: Support groups for breastfeeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 34983260

Group type: EXPERIMENTAL
Intervention: TEL-CBT (12 sessions)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: NHC
Number of subjects: 191
Study: 33337693

Group type: COMPARATOR
Intervention: CHO-only
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CHO-PRO
Number of subjects: 18